Table 1 The baseline characteristics of the study participants
Study cohort (n = 36) | Intervention group (n = 17) | Control group (n = 19) | |
|---|---|---|---|
Age at recruitment (years) | |||
Mean (min–max) | 7.8 (3–16) | 7.8 (3–16) | 7.9 (3–15) |
Gender (N, female:male) | 10:26 | 5:12 | 5:14 |
Diagnose | |||
Acute lymphocytic leukemia (SR:IR:HR) | 17 (8:6:3) | 7 (4:2:1) | 10 (4:4:2) |
Wilms’ tumor | 2 | 2 | 0 |
Burkitt lymphoma | 3 | 1 | 2 |
Non-Hodgkin lymphoma | 5 | 3 | 2 |
Hodgkin lymphoma | 3 | 1 | 2 |
Other neoplasm | 6 | 3 | 3 |
Vincristine/vinblastine during first 3 months from diagnose (mg/sqm) | |||
Mean (STD) | 10.2 (4.2) | 10.2 (4.0) | 10.1 (4.4) |
Min–Max | 1.4–17.5 | 3.3–16.2 | 1.4–17.5 |
Physical therapy (visits during the intervention period) | |||
Mean (STD) | 3 (2.2) | 2.4 (1.6) | 3.6 (2.6) |
Min–Max | 0–9 | 1–7 | 0–9 |
Days admitted (during the intervention period) | |||
Mean (STD) | 32.7 (13.6) | 30.5 (12.1) | 34.7 (14.8) |
Min–Max | 10–59 | 12–59 | 10–57 |
Hospital visits (during the intervention period) | |||
Mean (STD) | 11.2 (7.2) | 12.5 (7.4) | 10.1 (7.1) |
Min–Max | 1–35 | 4–35 | 1–26 |